About us

The India Health Fund (IHF), a collaborative initiative led by the Tata Trusts, endeavours to leverage the power of collective impact to eradicate tuberculosis (TB) by 2025 and malaria by 2030 from India.

The Tata Trusts partners Indian philanthropists and international and local donor agencies to support innovations and technologies designed to combat TB and malaria. IHF supplements and augments Government of India's (GoI) efforts to fight the epidemics.

IHF incorporated as Confluence for Health Action and Transformation Foundation, is a section 8 company registered under the Companies Act 2013. It is seeded by Tata Trusts with strategic support from the Global Fund.

Why TB and Malaria

TB and malaria, together, account for over 4.23 lakh (0.42 million) deaths annually in India alone. With over 8.5 million TB patients, the country accounts for 25 percent of the global TB burden. In 2016, a staggering 1.9 million TB cases were reported including 0.8 million new infectious cases. The economic cost of TB to the Indian economy has been pegged at US$3 billion (over Rs13,000 crore) annually.

Malaria results in high morbidity, mortality and economic loss each year. About 95 percent of India's population resides in malaria-endemic areas. ~1.12 million malaria cases were reported in India in 2016, according to the National Vector Borne Disease Control Program. The socio-economic burden due to malaria is pegged at around $1.94 billion (Rs11,640 crore) annually.

Current scenario


IHF envisages strengthening the health ecosystem by bridging the gap between lab to last mile population and translating the proof of concepts into impact. IHF aims to infuse contributions and strengthen capabilities to ultimately reduce human suffering by saving lives, reducing incidence and mitigation out of pocket expenditure.


IHF aims to create a platform for the private and public sector to initiate and scale up innovative solutions, business models and financing mechanisms to engender transformative change in the fight against malaria and TB in India.


  • 1 Mobilise and invest up to USD150 million over 5 years in scaling up high impact innovations in India.
  • 2 Promote and catalyse validated cutting-edge innovations that help in effective management of TB and malaria.
  • 3 Build a network of stakeholders, comprising the government, corporations, foundations and philanthropies, to boost the pool of resources, unlock opportunities and ideate for impact.
  • 4 Leverage core capacities of private sector to support strategic planning, implementation and evaluation of health programmes.
  • 5 Exchange best practices and infuse innovations within India and across the globe.
  • 6 Create sustainable self-supporting operational model to sustain and scale interventions in TB and malaria.

Innovation in TB and malaria

Tuberculosis and malaria are endemic diseases in India accounting for over 4.23 lakh (0.42 million) deaths annually. Innovative and 'out of the box' products and processes are needed to eliminate the diseases in the next decade. India Health Fund (IHF) aims to anchor such validated innovations and enable them to reach scale.

IHF collaborates with donors and investors to share investment decisions regarding raising and deployment of USD150 million to support strategic projects and solutions aimed at eliminaion of TB and malaria. Contributions from varied sources can be pooled as corpus or for specific areas.

An initiative by

Amongst India's oldest, non-sectarian philanthropic organisations, the Trusts have made a significant difference to communities for over a century through their grant-making, direct implementation and co-partnership strategies.

Founded in 2002, the Global Fund is a 21st-century partnership designed to promote innovative solutions to accelerate the end of AIDS, tuberculosis and malaria as epidemics.